You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CRNX Award Disclosure
Bedrosian Camille L · SEC Form 4 · Filed Jun 22, 2026
Award
Calculated transaction value
$0
Bedrosian Camille L Director
CRNX
Transaction date
Jun 18, 2026
Public filing date
Jun 22, 2026
Filing lag
Filed 4 days later
CRNX daily price context
Close on/before transaction
$35.87
Jun 18, 2026
First close after public filing
$35.91
Jun 23, 2026
30-day return after filing
+133.14%
Through Jul 22, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 5,925 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001628280-26-044712
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Crinetics Pharmaceuticals, Inc. CRNX | Award | Jun 18, 2026 | $0 |
| Crinetics Pharmaceuticals, Inc. CRNX Current | Award | Jun 18, 2026 | $0 |